Clinical Trial Update: Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining changes in gingival crevicular fluid levels of RANKL and osteoprotegerin in patients with chronic periodontitis, in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis
• Postmenopausal Osteoporosis

Snippet

Sponsor: Ondokuz Mayıs University | Conditions: Chronic Periodontitis | Phase 4 | Status: COMPLETED